Samples taken from Marion Biotech Noida facility sent to RDTL, Chandigarh for testing
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Surana is a chartered accountant with an all-India rank.
Subscribe To Our Newsletter & Stay Updated